ℹ️ No matches surfaced in the limited public sources we cover (sanctions, screening, insolvency, control). This is an automated indicator — not an exhaustive check, a credit decision, or a guarantee, and absence of a match does not mean none exists. Verify against the official register.
Think this is wrong? This is an automated estimate — request a human review or correction.
HAEMONETICS CORP
Company
Overview
HAEMONETICS CORP is a operating registered in BOSTON, United States. With reported revenue of 910.4M USD in 2015. Its TraceComp score of 49 (D) indicates elevated risk requiring further due diligence.
Company Information
- Registration Number
- 0000313143
- Legal Form
- Company
- Activity
- Surgical & Medical Instruments & Apparatus
- Address
- Boston
Financial Profile
Latest filed accounts: FY 2015 · most recent available in public filings
Multi-year financials & ratios
1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Research Output
Active research organization. 217 publications · 12,994 citations · h-index 62 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Medicine (85%) · Business, Management and Accounting (11%) · Biochemistry, Genetics and Molecular Biology (4%).
See full research profile — top researchers & publications →
Source: OpenAlex (CC0). Objective publication & citation counts.
Risk Signals
No adverse legal events have been recorded for this company.
- Profitable: positive net income in FY 2015
Similar Companies
Data Sources & Freshness
Data sourced from: official public registries. Profile completeness: 70%.